Market Tracker

04/17 6:02pm ET

Ligand Pharmaceuticals Inc (NASDAQ:LGND)

85.85
Delayed Data
As of Apr 17
 -1.00 / -1.15%
Today’s Change
41.99
Today|||52-Week Range
87.17
+61.34%
Year-to-Date

Today’s Trading

Previous close86.85
Today’s open86.06
Day’s range84.69 - 86.71
Volume690,083
Average volume (3 months)387,869
Market cap$1.7B
Dividend yield--
Data as of 4:00pm ET, 04/17/2015

Growth & Valuation

Earnings growth (last year)+31.55%
Earnings growth (this year)+41.78%
Earnings growth (next 5 years)+30.00%
Revenue growth (last year)+31.78%
P/E ratio153.3
Price/Sales16.83
Price/Book63.85

Competitors

 Today’s
change
Today’s
% change
SAGESAGE Therapeutics In...-1.39-2.27%
CMRXChimerix Inc-1.24-3.12%
NLNKNewLink Genetics Cor...-0.79-1.45%
ZIOPZIOPHARM Oncology In...-0.04-0.29%
Data as of 4:00pm ET, 04/17/2015

Financials

Next reporting dateMay 6, 2015
EPS forecast (this quarter)$0.27
Annual revenue (last year)$64.5M
Annual profit (last year)$12.0M
Net profit margin18.63%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
John L. Higgins
President &
Chief Operating Officer
Matthew W. Foehr
Corporate headquarters
La Jolla, California

Forecasts